Tourmaline Bio Inc. (TRML) — Financial Flexibility Index
Tourmaline Bio Inc. (TRML) has a Financial Flexibility Index of -2.01x as of June 2025. Free cash flow of $-20.26 Million (operating CF $-20.26 Million minus capex $7.00K) represents -2% of total liabilities ($10.10 Million). Check TRML capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tourmaline Bio Inc. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Tourmaline Bio Inc. across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Tourmaline Bio Inc. generate cash.
Annual Financial Flexibility Index for Tourmaline Bio Inc. (2019–2024)
Year-by-year free cash flow to debt coverage for Tourmaline Bio Inc.. Explore Tourmaline Bio Inc. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -8.63x | $-77.25 Million | $-77.26 Million | $8.95 Million | ▼ -61.8% |
| 2023 | -5.34x | $-28.02 Million | $-28.08 Million | $5.25 Million | ▼ -10965.4% |
| 2022 | -0.05x | $-1.39 Million | $-6.46 Million | $28.83 Million | ▲ +98.9% |
| 2021 | -4.36x | $-37.55 Million | $-39.99 Million | $8.61 Million | ▼ -16.1% |
| 2020 | -3.76x | $-17.93 Million | $-19.21 Million | $4.77 Million | ▲ +48.3% |
| 2019 | -7.26x | $-17.10 Million | $-17.66 Million | $2.35 Million | — |